Summary & Overview
HCPCS A9700: Injectable Contrast Material for Echocardiography, Per Study
HCPCS Level II code A9700 denotes the supply of injectable contrast material used for echocardiography on a per-study basis. The code captures the cost and billing for an ultrasound contrast agent provided to enhance cardiac imaging and improve diagnostic accuracy during transthoracic or transesophageal echocardiographic studies. Nationally, accurate coding for contrast supplies affects claim adjudication, facility and professional reimbursement relationships, and utilization monitoring for cardiac imaging services.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of where A9700 applies clinically, typical sites of service, and which payers commonly adjudicate supply charges separately from procedure fees. The publication outlines common modifiers encountered on related service lines and notes when supply reporting is typically expected versus bundled with procedural codes.
This resource provides benchmarks for code usage, policy context regarding separate supply billing for echocardiographic contrast, and the clinical rationale for contrast-enhanced echocardiography. It is intended to inform coding professionals, billing staff, and policy analysts about the role and billing considerations for HCPCS Level II code A9700 in routine cardiac imaging workflows.
Billing Code Overview
HCPCS Level II code A9700 describes the supply of injectable contrast material for use in echocardiography, per study. This item represents the provision of an ultrasound contrast agent administered intravenously to enhance cardiac ultrasound imaging during a single echocardiographic study.
Service Type: Contrast supply for echocardiography
Typical Site of Service: Hospital outpatient departments, ambulatory imaging centers, and physician offices where echocardiography is performed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient presents to the outpatient echocardiography laboratory with clinical questions about suspected intracardiac shunt or suboptimal endocardial border definition on standard transthoracic echocardiography. The patient is typically referred by a cardiologist or emergency physician for a contrast-enhanced transthoracic echocardiogram (TTE) to improve left ventricular opacification or to detect right-to-left shunt during bubble study. Typical workflow: the patient is registered in the echo lab; IV access is obtained; a sonographer performs baseline 2D and Doppler imaging; when endocardial borders remain poorly visualized or a bubble study is indicated, the echocardiography team prepares the supplied injectable contrast agent (A9700) per product instructions; the contrast is administered intravenously during image acquisition while the sonographer and interpreting cardiologist document enhanced opacification or evidence of shunt; images are archived and a final report is generated. Typical site of service is the hospital outpatient imaging department, hospital inpatient bedside echocardiography, or freestanding echocardiography clinic. Typical patient scenarios include poor acoustic windows (obesity, COPD, post-operative chest wall changes), evaluation for suspected patent foramen ovale or intracardiac shunt, and assessment of left ventricular function when standard imaging is nondiagnostic.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (standard) |